Is FAZE or MRK a better dividend investment in 2026?

FAZE currently yields 1095.89% with a 5% 5-year dividend growth rate. MRK yields 2.81% with 8.2% growth. The better choice depends on your goal: FAZE offers higher current income.

What is the dividend yield difference between FAZE and MRK?

FAZE has a forward dividend yield of 1095.89% ($2.00/share annually). MRK yields 2.81% ($3.32/share annually). The yield gap is 1093.08 percentage points.

Home › Compare › FAZE vs MRK

FAZE vs MRK: Dividend Comparison 2026

FAZE yields 1095.89% · MRK yields 2.81%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FAZE wins by $42056444.41M in total portfolio value

INVESTMENT

TIME HORIZON10 years

FAZE

● Live price

1095.89%

Share price

$0.18

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$42056444.47M

Annual income

$35,656,085,750,874.17

Full FAZE calculator →

MRK

Merck & Co. Inc.

● Live price

2.81%

Share price

$118.10

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$57.7K

Annual income

$10,113.78

Full MRK calculator →

Portfolio growth — FAZE vs MRK

📍 FAZE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FAZE	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FAZE + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FAZE pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FAZE

Annual income on $10K today (after 15% tax)

$93,150.68/yr

After 10yr DRIP, annual income (after tax)

$30,307,672,888,243.05/yr

MRK

Annual income on $10K today (after 15% tax)

$238.95/yr

After 10yr DRIP, annual income (after tax)

$8,596.71/yr

At 15% tax rate, FAZE beats the other by $30,307,672,879,646.33/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FAZE + MRK for your $10,000?

FAZE: 50%MRK: 50%

100% MRK50/50100% FAZE

Portfolio after 10yr

$21028222.26M

Annual income

$17,828,042,880,493.97/yr

Blended yield

84.78%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FAZE

No analyst data

Altman Z

-13.1

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+8.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FAZE buys

MRK buys

Politician	Chamber	Ticker	Type	Amount	Date
Josh Gottheimer	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2026-02-04
Michael McCaul	🏢 House	$MRK	▼ Sell	$15,001 - $50,000	2026-01-13
Gilbert Cisneros	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-12-19
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-12-18
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-11-13
Ro Khanna	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-09-29
Val Hoyle	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-09-23
Marjorie Taylor Greene	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-08-28
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-08-14
Gilbert Cisneros	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-08-05

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFAZEMRK

Forward yield	1095.89% ✓	2.81%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$42056444.47M ✓	$57.7K
Annual income after 10y	$35,656,085,750,874.17 ✓	$10,113.78
Total dividends collected	$41573433.88M ✓	$29.8K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: FAZE vs MRK ($10,000, DRIP)

Year	FAZE Portfolio	FAZE Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$120,289	$109,589.04	$11,213	$373.04	+$109.1K → FAZE
2	$1,360,706	$1,231,996.32	$12,667	$512.06	+$1.35M → FAZE
3	$14,480,535	$13,024,580.46	$14,439	$708.14	+$14.47M → FAZE
4	$145,033,136	$129,538,962.69	$16,640	$988.16	+$145.02M → FAZE
5	$1,367,734,329	$1,212,548,874.04	$19,432	$1,394.07	+$1367.71M → FAZE
6	$12,150,332,432	$10,686,856,700.26	$23,057	$1,992.90	+$12150.31M → FAZE
7	$101,727,206,751	$88,726,351,048.28	$27,889	$2,894.79	+$101727.18M → FAZE
8	$803,101,171,463	$694,253,060,239.29	$34,518	$4,286.29	+$803101.14M → FAZE
9	$5,981,643,663,638	$5,122,325,410,172.53	$43,912	$6,494.35	+$5981643.62M → FAZE
10	$42,056,444,470,967	$35,656,085,750,874.17	$57,714	$10,113.78	+$42056444.41M → FAZE

FAZE vs MRK: Complete Analysis 2026

FAZE — Stock

FaZe Holdings Inc. operates lifestyle and media platform in gaming and youth culture. The company produces content, designs merchandise and consumer products, and creates advertising and sponsorship programs for brands reaching approximately 500 million fans across social platforms. It delivers various entertainment spanning video blogs, lifestyle and branded content, gaming highlights, and live streams of competitive gaming tournaments. The company was founded in 2010 and is based in New York, New York.

Full FAZE Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this FAZE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FAZE vs SCHD FAZE vs JEPI FAZE vs O FAZE vs KO FAZE vs MAIN FAZE vs JNJ FAZE vs ABBV FAZE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.